7thSpace Interactive (press release) Patients were divided into two groups: patients who were commenced on atorvastatin 40 mg daily for two months followed by an individually matched dose of 10 or 20 mg/day (group A), and patients who were treated according to current recommendations ...
PipelineReview.com (press release) LIPTRUZET (pronounced LIP-true-zett) contains ezetimibe, an efficacious LDL cholesterol lowering therapy, and atorvastatin , currently one of the most widely prescribed statins in the U.S.[1] Once-daily LIPTRUZET treats two sources of cholesterol by ...
Forbes Ezetimibe, marketed as Zetia and, in combination with simvastatin , as Vytorin, was also a blockbuster, though in recent years its popularity has diminished as a result of controversy over the drug's research program and the lack of evidence ...
Forbes Zetia (generically known as ezetimibe) lowers low-density lipoprotein (LDL), the bad cholesterol involved in causing heart attacks and strokes, but less so than existing drugs like Lipitor (generically known as atorvastatin ), Crestor, from AstraZeneca, ...
Fox News ... secret shoppers called more than 200 U.S. pharmacies to price check 30-day supplies of five common genetic prescriptions: the diabetes drug Actos (pioglitazone), the antidepressant Lexapro (escitalopram), the cholesterol regulator Lipitor ... and more »
Pharmaceutical Business Review Baylor College of Medicine associate professor of medicine Peter Jones said, "Along with a healthy diet, LIPTRUZET (ezetimibe and atorvastatin ) is an effective new lipid-lowering treatment option that may help address this unmet need as the ...
Fort Mills Times Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved LIPTRUZET™ (ezetimibe and atorvastatin ) tablets for the treatment of elevated low-density ...
Business Wire (press release) LIPTRUZET (pronounced LIP-true-zett) contains ezetimibe, an efficacious LDL cholesterol lowering therapy, and atorvastatin , currently one...
